SYRE
Spyre Therapeutics, Inc. Common Stock ยท Health Care ยท NASDAQ
$100.32
โฒ $11.98 (+13.56%)
Market cap
$7.7B
52-week range
$14.00 โ $101.70
Volume
2.8M
Previous close
$88.34
Spyre Therapeutics, Inc. Common Stock (SYRE) is held by 4 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: RTW INVESTMENTS, LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
2.1% | 4.2M | $210M | โ | $21.52 | 2026-03-31 |
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
1.0% | 2.8M | $141M | โผ 3.2% (โ92K) | $12.25 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.3% | 1.0M | $50M | โ | $14.97 | 2026-03-31 |
| Carlyle Group Inc. Carlyle Group Inc. |
0.0% | 10K | $485K | โ | $21.20 | 2026-03-31 |
FAQ โพ
Which hedge funds hold SYRE?
Tracked holders include: RTW INVESTMENTS, LP, Driehaus Capital Management LLC, BAKER BROS. ADVISORS LP, Carlyle Group Inc..
How much smart money owns SYRE?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading SYRE?
No tracked Congressional trades in SYRE on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.